Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit
St. Jude Children's Research Hospital · with National Cancer Institute (NCI) · NCT06993688
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 85
- US sites recruiting
- 1
- Study start
- June 16, 2025
- Record last updated
- August 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to obtain insights and feedback from patients and parents about a new approach to support conversations about how cancer may affect one's future life and quality of life (i.e., prognostic communication). This study involves creating a personalized approach to discussing prognosis.
Primary Objectives
- To evaluate the feasibility of implementing the RIGHTimeCPV intervention among pediatric oncology patients, caregivers, and clinicians (referred to herein as "shareholders").
- To assess the acceptability of the intervention across the shareholder groups.
Secondary Objectives
- To explore the potential impact of the RIGHTimeCPV intervention on communication quality, concordance in prognostic understanding, and therapeutic alliance between patients/families and multidisciplinary clinicians.
- To explore whether the practice of eliciting, sharing, and honoring individualized communication preferences is sustained by clinicians after participation in the RIGHTimeCPV intervention.
Being studied: Prognostic Communication-Patient/parent; Prognostic Communication-CPC; Prognostic Communication-Oncologist
Conditions: Cancer; Communication
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria: Patients
- Aged 12-25 years diagnosed with poor prognosis cancer (high risk or otherwise difficult to treat cancers), as defined by a pediatric oncologist estimating odds of overall survival as 50% or less
- Anticipated by a pediatric oncologist to have one or more disease re-evaluation timepoints over the next six months
- Not anticipated by a pediatric oncologist to approach end of life in the next three months
Inclusion Criteria: Parents/Caregivers
- Aged 18 years or older and/or legally emancipated
- Parent or other self-identified caregiver of a patient of any age with poor prognosis cancer (as defined above)
Inclusion Criteria: Oncologists
- Pediatric oncologists who treat eligible patients/caregivers at the study site, St. Jude Children's Research Hospital (SJCRH) or its included affiliates:
- Peoria, IL: The Jim and Trudy Maloof St. Jude Midwest Affiliate Clinic
- Charlotte, NC: Novant Health Hemby Children's Hospital
- Shreveport, LA: Ochsner LSU Health-Feist-Weiller Cancer Center
Inclusion Criteria: Communication Preferences Companions (CPCs)
- Multidisciplinary clinicians from a participant's psychosocial or nursing care team, identified by that participant to serve as their 'communication preferences companion' (CPC) during the pilot
- Provides clinical care to pediatric cancer patients under the auspices of psychology, social work, spiritual care, child life, cultural navigation, quality of life/palliative care, or nursing
Exclusion Criteria
- Does not meet the stated inclusion criteria
Recruiting US locations
St. Jude Children's Research Hospital
Memphis, TN 38105
Site contact: Erica C. Kaye · 866-278-5833 · referralinfo@stjude.org
Study contacts (from the official record)
- Erica C. Kaye, MD, MPH · 866-278-5833 · referralinfo@stjude.org
Similar studies in Tennessee
All healthy volunteers studies in Tennessee →- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Cordova, TN + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Knoxville, TN + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Knoxville, TN + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.
Xfibra, Inc.
- Location
- Knoxville, TN
- Eligibility basics
- Ages 18–55